Back to search
FDAFDA · Food and drugs·Recall number Z-0752-2024

Calibration Serum Level 3 CAL2351

Published January 24, 2024 · Recall initiated: November 20, 2023

Summary

FDA records medical device Class II recall Z-0752-2024, published January 24, 2024 and initiated November 20, 2023. Recalling firm: Randox Laboratories Ltd.; Status: Ongoing; Reported quantity: 269 kits; Lot: GTIN: 05055273200966 Lot Numbers: 1214UE, 1249UE, 1260UE, 1262UE, 1268UE, 1297UE, 1298UE, 1315UE. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CK Total in Calibration Serum Level 3, CAL2351, is running with a positive bias on RX Series instruments compared to other methods experience a shift in Quality Control and patient sample recovery of up to 13%.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Randox Laboratories Ltd.
Distributor
US Nationwide and Puerto Rico.
Lot
GTIN: 05055273200966 Lot Numbers: 1214UE, 1249UE, 1260UE, 1262UE, 1268UE, 1297UE, 1298UE, 1315UE
Risk classification
Class II
Area (FDA)
device
Country
Ireland

Related recalls

Questions about this recall

Was Calibration Serum Level 3 CAL2351 recalled?

Yes. FDA published recall Z-0752-2024 on January 24, 2024. Reported hazard: CK Total in Calibration Serum Level 3, CAL2351, is running with a positive bias on RX Series instruments compared to other methods experience a shift in Quality Control and patient sample recovery of up to 13%.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail